Harmony Biosciences Holdings, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| HRMY | ACAD | ANRO | SANION.ST | AXSM | RYTM | |
|---|---|---|---|---|---|---|
| Market cap | 2.00B | 3.70B | 914.34M | 1.53B | 7.21B | 7.67B |
| P/E (TTM) | 11.4 | 9.6 | — | 8.6 | — | — |
| Forward P/E | 4.9 | 23.3 | -7.3 | — | 34.0 | -170.1 |
| Price/book | 2.3 | 3.0 | 3.7 | 2.8 | 68.3 | 87.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +18.09% | −7.88% | +101.06% | −36.20% | +2.89% | −13.10% |
| Today | −7.04% | +4.38% | +2.64% | +3.45% | −1.87% | +28.04% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All HRMY news ›Harmony Biosciences Plans CEO Transition for 2027
Nov 4, 2026 | Narcolepsy | 0 | Harmony Biosciences Holdings Inc has shared plans for a leadership succession, appointing Peter Anastasiou as its next president, CEO, and member of the board of directors, effective Jan 1, 2027. Anastasiou,…
Harmony Biosciences Q3 revenue misses estimates, profit falls on royalty charges
TradingView Harmony Biosciences Q3 revenue misses estimates, profit falls on royalty charges
Harmony Biosciences (NASDAQ:HRMY) Rating Lowered to Buy at Wall Street Zen
Posted by Tristan Rich on Nov 2nd, 2026 Harmony Biosciences (NASDAQ:HRMY – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday, Wall Street Zen…
Harmony Gold Mining (NYSE:HMY) Stock Bumped Down to Hold by Wall Street Zen
Posted by Sarita Garza on Nov 2nd, 2026 Wall Street Zen downgraded shares of Harmony Gold Mining (NYSE:HMY – Free Report) from a buy rating to a hold rating in a research report report published on Sunday morning,Wall Street Zen reports.…
More from 1 other outlet
Harmony Biosciences Grapples With A Leadership Transition That Spooked Investors
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
BlackRock Discloses 12.6% Ownership Stake in Harmony Biosciences Holdings
Airbnb (NASDAQ:ABNB) Grinds Higher as Chart Coils Below Resistance PayPal Holdings (NASDAQ:PYPL) Slips As Chart Tests Support Zone Can Ulta Beauty (NASDAQ:ULTA) Maintain Growth Amid Rising Competition? Why Is Ross Stores (NASDAQ:ROST)…
Harmony Biosciences drops amid court hearing on Wakix patent
Harmony Biosciences fell after a Wakix patent court hearing. mohd izzuan/iStock via Getty Images Harmony Biosciences (HRMY) quickly fell 7% amid a court hearing over a patent for its Wakix drug. The closing arguments regarding the ANDA…
Centene, Harmony Biosciences lead list of undervalued healthcare stocks
(XLV:NYSEARCA) Seeking Alpha iQoncept/iStock via Getty Images As the third-quarter 2026 earnings season unfolds, investors are assessing valuations across the U.S. healthcare sector, which spans health insurers, healthcare serv
Harmony Biosciences: A Cash Machine With A Patent Ruling Hanging Over It
(NASDAQ:HRMY) Seeking Alpha - Harmony Biosciences is rated Buy with a 12-month price target of $43, reflecting strong cash generation and WAKIX growth. - HRMY's valuation is supported by WAKIX's robust performance, cash reserve
Technical indicators turn bullish for former Barron's stock picks Marriott, Logitech, and Harmony Biosciences.
Former Barron's Investor Circle stock picks Marriott, Logitech, and Harmony Biosciences have seen their technical indicators shift to a bullish trend. This review highlights the importance of revisiting past stock recommendations to assess…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- tradingview.com5
- seekingalpha.com4
- themarketsdaily.com4
- defenseworld.net3
- investors.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 29 articles, not a forecast.